These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9773159)
1. [Hepatocellular carcinoma, a malignant tumor diagnosed with more frequency]. Daruich JR Acta Gastroenterol Latinoam; 1998; 28(3):273-6. PubMed ID: 9773159 [No Abstract] [Full Text] [Related]
2. Surveillance for hepatocellular carcinoma in patients with liver cirrhosis in India. Aggarwal R Trop Gastroenterol; 2008; 29(4):183-6. PubMed ID: 19323085 [No Abstract] [Full Text] [Related]
3. Hepatocellular carcinoma--screening and latency period. Trotter D West J Med; 1986 Mar; 144(3):363. PubMed ID: 3008444 [No Abstract] [Full Text] [Related]
6. Screening for hepatocellular carcinoma in high-risk patients: Western versus Eastern virus. Huo TI; Lee SD; Wu JC Hepatology; 2003 Jul; 38(1):269; author reply 270. PubMed ID: 12830012 [No Abstract] [Full Text] [Related]
7. Hepatocellular carcinoma in young adults. Albukerk J N Y State J Med; 1981 Aug; 81(9):1341-3. PubMed ID: 6267529 [No Abstract] [Full Text] [Related]
9. Screening for hepatocellular carcinoma in clinical practice: miles to go before we sleep. Kallwitz ER; Cotler SJ J Clin Gastroenterol; 2007 Sep; 41(8):729-30. PubMed ID: 17700420 [No Abstract] [Full Text] [Related]
10. The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations. Rivenbark AG; Coleman WB Clin Cancer Res; 2007 Apr; 13(8):2309-12. PubMed ID: 17438087 [No Abstract] [Full Text] [Related]
11. Serological surveillance for hepatocellular carcinoma: time to quit. Sherman M J Hepatol; 2010 Apr; 52(4):614-5. PubMed ID: 20185193 [No Abstract] [Full Text] [Related]
12. Surveillance and diagnosis for hepatocellular carcinoma. Aljabiri MR; Lodato F; Burroughs AK Liver Transpl; 2007 Nov; 13(11 Suppl 2):S2-12. PubMed ID: 17969087 [No Abstract] [Full Text] [Related]
13. HCC surveillance: who is the target population? Bruix J; Llovet JM Hepatology; 2003 Mar; 37(3):507-9. PubMed ID: 12601346 [No Abstract] [Full Text] [Related]
14. [Screening for hepatocellular carcinoma in cirrhotic patients]. Beaugrand M Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B92-4. PubMed ID: 10891771 [No Abstract] [Full Text] [Related]
15. Primary carcinoma of the liver in east Pakistan. Islam N; Mahtab H; Khan AK J Trop Med Hyg; 1968 Aug; 71(8):206-11. PubMed ID: 4299206 [No Abstract] [Full Text] [Related]
16. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey. Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632 [TBL] [Abstract][Full Text] [Related]
17. Advances in prevention and diagnosis of hepatocellular carcinoma. Spangenberg HC; Thimme R; Blum HE Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):425-33. PubMed ID: 19072390 [TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy]. Tischoff I; Tannapfel A Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632 [TBL] [Abstract][Full Text] [Related]